Fibrinliimoja

Fibrinliimoja are medical adhesives primarily composed of fibrinogen and thrombin. These two components, when mixed, mimic the natural clotting cascade of the body to form a stable fibrin clot. This process effectively seals wounds and joins tissues. Fibrinliimoja are derived from human plasma, a process that ensures compatibility with the patient's own biological systems.

The primary application of fibrinliimoja is in surgery, where they are used to promote hemostasis (stopping bleeding) and to serve as a tissue sealant. They can be particularly useful in delicate procedures or in areas where conventional suturing or stapling is difficult or may cause damage. Examples include neurosurgery, liver surgery, and reconstructive surgery. They can also be used to reattach skin grafts and to seal air leaks in lung surgery.

The use of fibrinliimoja offers several advantages. They are biocompatible and biodegradable, meaning the body naturally absorbs them over time. They can also facilitate wound healing by providing a scaffold for cell migration and proliferation. However, like any medical product, they carry potential risks, including allergic reactions and the transmission of infectious agents, although rigorous screening and viral inactivation processes significantly minimize these risks. The development and application of fibrinliimoja represent an important advancement in surgical techniques and wound management.